Genscript Biotech Corporation (GNNSF)
Total Current Liabilities
$726.58M
Quarterly · Period ending: · USD

GNNSF Total Current Liabilities
What is total current liabilities?
Liabilities due within one year.
GNNSF total current liabilities history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it.
| Period ending | Total Current Liabilities (USD) | Change |
|---|---|---|
| 720,075,232 | +134.29% | |
| 307,342,000 | −37.89% | |
| 494,811,000 | −9.37% | |
| 545,978,000 | +17.57% | |
| 464,367,000 | +41.61% | |
| 327,911,000 | +46.06% | |
| 224,505,000 | +46.24% | |
| 153,515,000 | −43.71% | |
| 272,716,000 | +595.44% | |
| 39,215,000 | +26.93% | |
| 30,894,000 | +5.84% | |
| 29,188,000 | −2.33% | |
| 29,885,000 | — |
Frequently asked questions: GNNSF total current liabilities
What is Genscript Biotech Corporation (GNNSF)'s current total current liabilities?
Genscript Biotech Corporation (GNNSF)'s latest reported total current liabilities (Quarterly) is $726.58M as of Jun 30, 2026. Liabilities due within one year.
How much historical total current liabilities data is available for GNNSF?
Stock Alarm Pro provides 13 dated annual fiscal periods observations for Genscript Biotech Corporation (GNNSF)'s total current liabilities, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.
How can I compare GNNSF's total current liabilities to peers or set an alert?
You can open GNNSF's total current liabilities in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on GNNSF delivered by push, email, or phone call.
Explore More
Explore 130+ historical metrics & ratios
Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance